Coleen Glessner - 13 Mar 2024 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EBS	Employee Stock Options (Right to Buy)	Award	$0	+125,000	+201%	$0.000000	187,113	13 Mar 2024	Common Stock	125,000	$2.33	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Vests in three equal installments beginning on the day prior to the anniversary date of the grant.